Effectiveness of Acetazolamide in Reducing Paralysis of the Leg in Patients Undergoing Aortic Aneurysm Surgery Surgery

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT01889498

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01889498
  • EudraCT 2013-001447-31
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01889498. Randomized; no masking; primary purpose treatment. Start 2014-07 (registry gives no type); primary completion 2016-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effectiveness of Acetazolamide in Reducing Paralysis of the Leg in Patients Undergoing Aortic Aneurysm Surgery Surgery
Acronym
AZATAAR
Condition
Thoracic Aneurysm
Intervention (Drug)
Acetazolamide
Lead sponsor
Liverpool Heart and Chest Hospital NHS Foundation Trust (class: other)

Record details

Record id
cardio:ct-nct01889498
Content hash
b341154ad60a422856c68e4928c684b72cd53a42d9d7d119f4f9c10f670ab03d